C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/54 (2006.01) A61K 31/395 (2006.01) C07D 231/12 (2006.01) C07D 237/04 (2006.01) C07D 237/08 (2006.01) C07D 261/08 (2006.01)
Patent
CA 2525437
The present invention provides benzamide inhibitors of the P2X7 receptor of the formula (I), wherein R1 -R3 are as defined herein. The compounds of the invention are useful in the treatment of IL-1 mediated disorders, including, without limitation, inflammatory diseases such as osteoarthritis and rheumatoid arthritis; allergies, asthma, COPD, cancer, reperfusion or ischemia in stroke or heart attack, autoimmune diseases and other disorders.
La présente invention se rapporte à des inhibiteurs benzamidiques du récepteur P2X¿7? répondant à la formule (I), dans laquelle R?1¿ à R?3¿ ont les définitions données dans la description. Les composés selon l'invention sont utilisables dans le traitement des troubles à médiation par IL-1, à savoir notamment mais non exclusivement les maladies inflammatoires telles que l'arthrose et l'arthrite rhumatoïde ; les allergies, l'asthme, la bronchopneumopathie chronique obstructive, les cancers, la reperfusion ou l'ischémie en cas d'accident vasculaire cérébral ou d'infarctus, les maladies auto-immunes et d'autres troubles.
Dombroski Mark Anthony
Duplantier Allen Jacob
Subramanyam Chakrapani
Pfizer Products Inc.
Smart & Biggar
LandOfFree
Benzamide inhibitors of the p2x7 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzamide inhibitors of the p2x7 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzamide inhibitors of the p2x7 receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1970490